X Financial names Kan Li acting chief risk officer By Investing.com

X Financial said Chief Risk Officer Yufan Jiang will resign effective July 1, 2026, and Acting CRO Kan Li will step in while continuing as President and Director. The company also reported Q1 2026 net revenue of $170.5 million, down 39.3% year over year, reflecting weaker origination activity and elevated credit costs. Despite a sequential margin improvement, profitability remains under pressure and the stock has fallen 68% over the past year to $4.95.

Analysis

This is less a routine management shuffle than a signal that the company is tightening control over the risk function at a point when underwriting quality is already under stress. Reinstalling a former CRO who now also runs the business suggests the board is prioritizing continuity and faster decision-making over separation of duties, which can stabilize operations in the near term but often precedes a more conservative growth posture. That usually matters most for platform lenders because the market tends to re-rate them on incremental credit performance, not on nominal loan growth.

The second-order implication is that the firm may be entering a longer period of capital-light, lower-growth economics as it protects book quality. If origination remains subdued and credit costs stay elevated, the earnings inflection is likely months away at best, and any near-term revenue stabilization could be mechanically driven by lower provisioning rather than true demand recovery. For peers, this is modestly positive for better-capitalized lenders and funding partners with stronger underwriting discipline, because a weaker operator pulling back can improve pricing rationality in a crowded segment.

The stock’s valuation may look optically cheap, but that can be a trap when the dividend and reported earnings are both vulnerable to another leg of credit deterioration. The main catalyst that would reverse sentiment is evidence of normalized originations without a step-up in delinquency or charge-offs; absent that, the market will likely treat management changes as defensive rather than constructive. The contrarian angle is that the appointment of a seasoned risk veteran could reduce tail risk enough to support the equity floor, but only if investors believe governance is improving faster than the loan book is degrading.

Key Decisions for Investors

• Avoid adding to XYF until the next quarterly update confirms stable delinquencies and provisioning; near-term upside is limited and downside remains tied to credit surprises over the next 1-2 quarters.
• For existing XYF longs, consider a partial hedge via short-dated puts or a collar into earnings; the risk/reward favors protecting against a 15-25% drawdown if credit metrics deteriorate again.
• Relative-value idea: long higher-quality consumer finance or fintech lenders with cleaner credit trends, short XYF as the weaker underwriting name; this isolates governance/credit dispersion over the next 3-6 months.
• If XYF sells off further into low single digits without new credit stress, consider a tactical trading long only on confirmation that the acting CRO has not changed risk appetite materially; target a mean-reversion pop, but keep sizing small due to balance-sheet uncertainty.